Home

Blot Schließen Begleiten genentech nik inhibitor canada Fonds Beitreten Renaissance

PDF) Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing  Kinase (NIK) as Anti-Cancer Drug Targets
PDF) Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets

NIKing BAFF's limelight | Nature Reviews Rheumatology
NIKing BAFF's limelight | Nature Reviews Rheumatology

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A

Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB  (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets

The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK)  inhibitors with anti-inflammatory effects in vitro, low toxicities against  T cell growth - ScienceDirect
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect

NIK promotes tissue destruction independently of the alternative NF-κB  pathway through TNFR1/RIP1-induced apoptosis | Cell Death & Differentiation
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis | Cell Death & Differentiation

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors  That Have High Selectivity over Phosphoinositide-3-k
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-k

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A

Small molecule approaches to treat autoimmune and inflammatory diseases  (Part I): Kinase inhibitors - ScienceDirect
Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors - ScienceDirect

NF-κB inducing kinase is a therapeutic target for systemic lupus  erythematosus | Nature Communications
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A

Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors  That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal  of Medicinal Chemistry
Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) | Journal of Medicinal Chemistry

The structure of Amgen NIK compounds. | Download Scientific Diagram
The structure of Amgen NIK compounds. | Download Scientific Diagram

Kinase inhibition in autoimmunity and inflammation | Nature Reviews Drug  Discovery
Kinase inhibition in autoimmunity and inflammation | Nature Reviews Drug Discovery

NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine
NIK as a Druggable Mediator of Tissue Injury: Trends in Molecular Medicine

The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK)  inhibitors with anti-inflammatory effects in vitro, low toxicities against  T cell growth - ScienceDirect
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect

IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic

Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor  That Has Anti-inflammatory Effects in Vitro and in Vivo | Journal of  Medicinal Chemistry
Discovery of a Potent and Selective NF-κB-Inducing Kinase (NIK) Inhibitor That Has Anti-inflammatory Effects in Vitro and in Vivo | Journal of Medicinal Chemistry

Transcreener ADP Assay Enables Evaluation of NIK Inhibitors in Lupus Drug  Discovery - BellBrook Labs
Transcreener ADP Assay Enables Evaluation of NIK Inhibitors in Lupus Drug Discovery - BellBrook Labs

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases. - Abstract - Europe PMC
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases. - Abstract - Europe PMC

NF-κB Signaling | NF-kappaB Pathway
NF-κB Signaling | NF-kappaB Pathway

Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small  molecules for the treatment of human diseases - RSC Medicinal Chemistry  (RSC Publishing) DOI:10.1039/D0MD00361A
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A

NF-κB inducing kinase is a therapeutic target for systemic lupus  erythematosus | Nature Communications
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications